Ensign Peak Advisors, Inc

Position in ALXO — Alx Oncology Holdings Inc

CIK 1454984 SALT LAKE CITY, UT

Position in ALXO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,677,314

-$228,538 QoQ

Shares Held

810,297

-14.8% QoQ

Ownership

0.586%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#22

of 94 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. ALXO ranks #71 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,483	$104,553,220
2	INSM	INSMED Inc	702,951	$74,948,635
3	ABVX	Abivax S.A.	504,471	$67,225,805
4	BBIO	BridgeBio Pharma, Inc.	760,977	$56,677,566
5	ARGX	Argenx SE	52,027	$48,269,089
6	PTCT	Ptc Therapeutics, Inc.	508,056	$41,442,127
7	TVTX	Travere Therapeutics, Inc.	591,815	$33,621,010
8	SRRK	Scholar Rock Holding Corp	579,052	$31,847,860

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,677,314	810,297	-14.8%	Shares	Sole	2026-08-14
2026-03-31	$1,905,852	950,550	+70311.1%	Shares	Sole	2026-05-13
2022-06-30	$10,921	1,350	-98.9%	Shares	Sole	2022-08-12
2022-03-31	$2,153,600	127,432	0.0%	Shares	Sole	2022-05-16
2021-12-31	$2,738,513	127,432	-63.1%	Shares	Sole	2022-02-11
2021-09-30	$25,517,448	345,484	-8.3%	Shares	Sole	2021-11-12
2021-06-30	$20,606,978	376,865	+12.1%	Shares	Sole	2021-08-13
2021-03-31	$24,798,688	336,299	+1143.5%	Shares	Sole	2021-05-12
2020-12-31	$2,331,192	27,044	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.